News
A meta-analysis suggests allogeneic stem cell transplantation (allo-SCT) should not be recommended following first-line ...
Alfred L. Garfall, MD, provided a deep dive into the phase 2 BMT CTN 1902 trial of ide-cel in multiple myeloma after ...
Stem cells can fight disease from the inside out. But spas and clinics are selling treatments that are unproven, expensive, ...
Kennedy, Jr. doubled down on his support for non-pharmaceutical health treatments during a recent podcast appearance, saying, ...
Brainstorm tapped Minaris to manufacture NurOwn for its upcoming Phase 3b clinical trial testing the treatment for ALS.
At 38, author Jonathan Gluck was diagnosed with blood cancer and given less than three years to live. Twenty-two years later, ...
Only a handful of stem cell therapies are currently approved by the F.D.A., mainly for treating blood cancer and immune ...
The U.S. health secretary said people should have access to experimental therapies including unregulated uses of stem cells.
New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...
A Falmouth teen, Jayden Wilsey, is the first to receive gene therapy to treat sickle cell at Boston Children's Hospital.
Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, have found that gene editing using ...
Researchers have identified an early postnatal window that allows gene transfer to circulating blood stem cells, advancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results